During the meeting we will explore the latest developments in research into the causes of atherosclerosis and related vascular disease, and how these may affect the clinical guidelines for diagnosis and treatment.
One of the features of EAS Congress is the high-level interdisciplinary exchange between clinicians and basic researchers. With many world-leading experts already confirmed, the EAS 2020 Geneva scientific programme will offer a bench-to-bedside overview of the latest current research in the field - including the award-winning Anitschkow Lecture, outstanding Keynote Lectures, state-of-the-art Plenary Sessions, and focused Workshops and Advance Clinical Seminars.
Our team is going to be present with our poster - The next step in the clinical use of microRNAs: the elimination of heparin interference, so do not hesitate to join us at EAS 2020!